{"title":"Unraveling the Role of Formulation Parameters in Protein Particle Formation at Moving Interfaces Using Molecular Dynamics and Experiments.","authors":"Tim Sarter, Wolfgang Friess","doi":"10.1021/acs.molpharmaceut.5c00330","DOIUrl":null,"url":null,"abstract":"<p><p>Interfacial stress during peristaltic pumping can lead to particle formation in biopharmaceutical solutions. Since the impact of formulation on protein particle formation is not fully understood, we combined molecular dynamics (MD) simulations with experimental methods to investigate and understand the effects of pH, ionic strength, and protein type during peristaltic pumping. Building on our previous work, we improved the MD model to provide a more accurate representation of a protein solution at the polymer interface. Our results indicate that the pH value affects aggregate formation in a human growth hormone solution, both while protein molecules are adsorbed to the interface and during the detachment of aggregates into the bulk. Both steps were also directly influenced by protein-protein interactions. Studies at high ionic strength suggest that when protein self-interaction is similar, the amount of protein molecules adsorbed to the interface can be decisive of the extent of particle formation. Additional studies employing lysozyme as a second protein confirmed that protein-protein interactions are the key factor in protein aggregation at interfaces, validating the MD model and our findings across different low-molecular-weight proteins. Our study uncovers the specific points of action through which formulation parameters influence protein particle formation upon mechanical interfacial stress. Furthermore, our model enables the prognosis of protein particle formation <i>in silico</i>, potentially saving resources in formulation and process development.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":" ","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.molpharmaceut.5c00330","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Interfacial stress during peristaltic pumping can lead to particle formation in biopharmaceutical solutions. Since the impact of formulation on protein particle formation is not fully understood, we combined molecular dynamics (MD) simulations with experimental methods to investigate and understand the effects of pH, ionic strength, and protein type during peristaltic pumping. Building on our previous work, we improved the MD model to provide a more accurate representation of a protein solution at the polymer interface. Our results indicate that the pH value affects aggregate formation in a human growth hormone solution, both while protein molecules are adsorbed to the interface and during the detachment of aggregates into the bulk. Both steps were also directly influenced by protein-protein interactions. Studies at high ionic strength suggest that when protein self-interaction is similar, the amount of protein molecules adsorbed to the interface can be decisive of the extent of particle formation. Additional studies employing lysozyme as a second protein confirmed that protein-protein interactions are the key factor in protein aggregation at interfaces, validating the MD model and our findings across different low-molecular-weight proteins. Our study uncovers the specific points of action through which formulation parameters influence protein particle formation upon mechanical interfacial stress. Furthermore, our model enables the prognosis of protein particle formation in silico, potentially saving resources in formulation and process development.
期刊介绍:
Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development.
Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.